# Pre-Storage Leukocyte Reduction of Whole Blood and Blood Components Intended for Transfusion:  Final Guidance for Industry - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/pre-storage-leukocyte-reduction-of-whole-blood-and-blood-components-intended-for-transfusion-final-guidance-for-industry/2237da2a-80aa-4592-b97f-a58f86a9a7ca

> FDA guidance document: Pre-Storage Leukocyte Reduction of Whole Blood and Blood Components Intended for Transfusion:  Final Guidance for Industry. Issue date: September 01, 2012. Get complete insights and analysis.

---

## Details

- Title: Pre-Storage Leukocyte Reduction of Whole Blood and Blood Components Intended for Transfusion:  Final Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2012-09-01
- Last Changed: 2019-05-15
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2001-D-0254">FDA-2001-D-0254</a>

## Related Documents

- [Clinical Considerations for Therapeutic Cancer Vaccines:  Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/clinical-considerations-for-therapeutic-cancer-vaccines-guidance-for-industry/e0e6e4e0-a883-4f71-bf37-784e147d32d9)
- [Preclinical Assessment of Investigational Cellular and Gene Therapy Products:  Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/preclinical-assessment-of-investigational-cellular-and-gene-therapy-products-guidance-for-industry/e4aedc4e-81e3-4d2e-b655-2460ccf3a04e)
- [Blood Establishment Computer System Validation in the User's Facility:  Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/blood-establishment-computer-system-validation-in-the-users-facility-guidance-for-industry/0d458283-d7d4-4dbf-b665-009d53641a92)